Literature DB >> 27912993

Rehabilitation in Chronic Graft-Versus-Host Disease.

Sean Robinson Smith1, Arash Asher2.   

Abstract

Chronic graft-versus-host disease is a potentially debilitating complication of allogeneic hematopoietic stem cell transplantation. Due to the direct inflammatory effects of the disease on tissue, and the impact on muscle and bone of the high-dose glucocorticoid immunosuppression used to treat the disease, patients are at risk of developing multifactorial functional impairment. This review outlines the clinical assessment and rehabilitation interventions to manage aspects of the disease that cause the most impairment: involvement of the skin/fascial and cardiopulmonary organ systems, as well as steroid-induced myopathy and bone and joint destruction. Copyright Â
© 2016 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Bone marrow transplant rehabilitation; Cancer rehabilitation; Chronic graft-versus-host disease; GVHD; GVHD rehabilitation

Mesh:

Year:  2017        PMID: 27912993     DOI: 10.1016/j.pmr.2016.08.009

Source DB:  PubMed          Journal:  Phys Med Rehabil Clin N Am        ISSN: 1047-9651            Impact factor:   1.784


  2 in total

Review 1.  Graft versus host disease-related eosinophilic fasciitis: cohort description and literature review.

Authors:  Cristina Hidalgo Calleja; Daniel Martín Hidalgo; Concepción Román Curto; Lourdes Vázquez López; Estefanía Pérez López; Mónica Cabrero Calvo; Ana África Martín López; María Dolores Caballero Barrigón; Lucía Lopez-Corral
Journal:  Adv Rheumatol       Date:  2022-08-23

2.  Osteopathic Treatment and Evaluation in the Clinical Setting of Childhood Hematological Malignancies.

Authors:  Monica Barbieri; William Zardo; Chiara Frittoli; Clara Rivolta; Valeria Valdata; Federico Bouquin; Greta Passignani; Alberto Maggiani; Momcilo Jankovic; Andrea Cossio; Andrea Biondi; Adriana Balduzzi; Francesca Lanfranconi
Journal:  Cancers (Basel)       Date:  2021-12-16       Impact factor: 6.639

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.